The store will not work correctly when cookies are disabled.
7-(pyridin-3-yl)-1-(pyrrolidin-1-yl)heptan-1-one
ID: ALA4587391
PubChem CID: 155566488
Max Phase: Preclinical
Molecular Formula: C16H24N2O
Molecular Weight: 260.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCCCCCc1cccnc1)N1CCCC1
Standard InChI: InChI=1S/C16H24N2O/c19-16(18-12-5-6-13-18)10-4-2-1-3-8-15-9-7-11-17-14-15/h7,9,11,14H,1-6,8,10,12-13H2
Standard InChI Key: KSLCJAODXAJLBZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
36.8644 -19.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5721 -19.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2798 -19.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1567 -19.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4490 -19.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7413 -19.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0336 -19.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3259 -19.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6182 -19.9386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3259 -18.7129 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.8682 -19.6047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3214 -20.2120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7300 -20.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5293 -20.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2773 -20.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9842 -21.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6929 -20.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6902 -19.9353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9828 -19.5305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
3 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 3 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 260.38 | Molecular Weight (Monoisotopic): 260.1889 | AlogP: 3.20 | #Rotatable Bonds: 7 |
Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.56 | CX LogP: 2.66 | CX LogD: 2.66 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.71 | Np Likeness Score: -0.84 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |